Chemotherapy, AdjuvantAdjuvants, ImmunologicRadiotherapy, AdjuvantBreast NeoplasmsAdjuvants, PharmaceuticFreund's AdjuvantCombined Modality TherapyTamoxifenNeoplasm StagingNeoplasm Recurrence, LocalDisease-Free SurvivalLevamisoleAntineoplastic Agents, HormonalFluorouracilPrognosisTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsLymphatic MetastasisSurvival AnalysisSurvival RateAromatase InhibitorsAntineoplastic AgentsAdenocarcinomaFollow-Up StudiesNeoadjuvant TherapyReceptors, EstrogenCyclophosphamideScleral DiseasesRetrospective StudiesMastectomyColonic NeoplasmsRandomized Controlled Trials as TopicNitrilesLymph Node ExcisionRectal NeoplasmsTriazolesClinical Trials as TopicChemoradiotherapy, AdjuvantLymph NodesTumor Markers, BiologicalPancreatic NeoplasmsAntimetabolites, AntineoplasticLeucovorinDoxorubicinReceptors, ProgesteroneMethotrexateKaplan-Meier EstimateMelanomaTime FactorsProportional Hazards ModelsSemustineReceptor, erbB-2PostmenopauseColorectal NeoplasmsNeoplasms, Hormone-DependentDrug Administration ScheduleAluminum HydroxideNeoplasm MetastasisAnthracyclinesNeoplasm InvasivenessImmunotherapyCarcinomaMucoepidermoid TumorToremifenePancreatectomyNova ScotiaImmunohistochemistryMedical OncologyTegafurMultivariate AnalysisAxillaOptic Nerve NeoplasmsRecurrenceAmenorrheaProspective StudiesBone Marrow NeoplasmsPostoperative CareMenopausePredictive Value of TestsCancer VaccinesSkin NeoplasmsMice, Inbred BALB CEpirubicinCisplatinLung NeoplasmsEstrogen Receptor ModulatorsImmunizationPancreaticoduodenectomyActuarial AnalysisGoserelinMastectomy, SegmentalMastectomy, Modified RadicalPremenopauseBrain NeoplasmsEndometrial NeoplasmsClinical Trials, Phase III as TopicBone NeoplasmsGastrectomyStomach NeoplasmsInterferon-alpha